United States - English - NLM (National Library of Medicine)

physicians total care, inc. - albuterol sulfate (unii: 021sef3731) (albuterol - unii:qf8svz843e) - albuterol sulfate 2.5 mg in 3 ml - albuterol sulfate inhalation solution is indicated for the relief of bronchospasm in patients 2 years of age and older with reversible obstructive airway disease and acute attacks of bronchospasm. albuterol sulfate inhalation solution is contraindicated in patients with a history of hypersensitivity to any of its components.

United States - English - NLM (National Library of Medicine)

actavis pharma, inc. - albuterol sulfate (unii: 021sef3731) (albuterol - unii:qf8svz843e) - albuterol 0.63 mg in 3 ml - albuterol sulfate inhalation solution is indicated for the relief of bronchospasm in patients 2 to 12 years of age with asthma (reversible obstructive airway disease). albuterol sulfate inhalation solution is contraindicated in patients with a history of hypersensitivity to any of its components. read this patient information completely every time your prescription is filled as information may have changed. keep these instructions with your medication, as you may want to read them again. albuterol sulfate inhalation solution should only be used under the direction of a physician. your physician and pharmacist have more information about albuterol sulfate inhalation solution and the condition for which it has been prescribed. contact them if you have additional questions. storing your medicine store albuterol sulfate inhalation solution between 20° and 25° c (68° and 77° f). [see usp controlled room temperature]. vials should be protected from light before use, therefore, keep unused vials in the foil pouch. d

United States - English - NLM (National Library of Medicine)

mylan pharmaceuticals inc. - albuterol sulfate (unii: 021sef3731) (albuterol - unii:qf8svz843e) - albuterol 0.75 mg in 3 ml - albuterol sulfate inhalation solution is indicated for the relief of bronchospasm in patients 2 to 12 years of age with asthma (reversible obstructive airway disease). albuterol sulfate inhalation solution is contraindicated in patients with a history of hypersensitivity to any of its components.

United States - English - NLM (National Library of Medicine)

nephron pharmaceuticals corporation - albuterol sulfate (unii: 021sef3731) (albuterol - unii:qf8svz843e) - albuterol 1.25 mg in 3 ml - albuterol sulfate inhalation solution is indicated for the relief of bronchospasm in patients 2 to 12 years of age with asthma (reversible obstructive airway disease). albuterol sulfate inhalation solution is contraindicated in patients with a history of hypersensitivity to any of its components.

United States - English - NLM (National Library of Medicine)

akorn - albuterol sulfate (unii: 021sef3731) (albuterol - unii:qf8svz843e) - albuterol 5 mg in 1 ml - albuterol sulfate inhalation solution is indicated for the relief of bronchospasm in patients 2 years of age and older with reversible obstructive airway disease and acute attacks of bronchospasm. albuterol sulfate inhalation solution is contraindicated in patients with a history of hypersensitivity to albuterol or any of its components. albuterol sulfate inhalation solution, 0.5%* *potency expressed as albuterol note: the albuterol sulfate inhalation solution contained in the 20 ml multiple-dose bottles is concentrated and must be diluted. read complete instructions carefully before using. 1. draw the appropriate volume of albuterol sulfate inhalation solution, 0.5% into the specially marked dropper that comes with each multidose bottle (figure 1). for children 12 years of age and under, the volume is based upon body weight. use the dropper volume prescribed by your doctor. figure 1 2. squeeze the solution into the nebulizer reservoir through the appropriate opening, taking care not to touch the tip of the d

United States - English - NLM (National Library of Medicine)

rebel distributors corp. - albuterol sulfate (unii: 021sef3731) (albuterol - unii:qf8svz843e) - albuterol 5 mg in 1 ml - albuterol sulfate inhalation solution is indicated for the relief of bronchospasm in patients 2 years of age and older with reversible obstructive airway disease and acute attacks of bronchospasm. albuterol sulfate inhalation solution is contraindicated in patients with a history of hypersensitivity to albuterol or any of its components. albuterol sulfate inhalation solution, 0.5%* *potency expressed as albuterol note: the albuterol sulfate inhalation solution contained in the 20 ml multiple-dose bottles is concentrated and must be diluted. read complete instructions carefully before using. 1. draw the appropriate volume of albuterol sulfateinhalation solution, 0.5% into the specially marked dropper that comes with each multidose bottle (figure 1). for children 12 years of age and under, the volume is based upon body weight. use the dropper volume prescribed by your doctor. figure 1 2 . squeeze the solution into the nebulizer reservoir through the appropriate opening, taking care not to touch the tip of the

United States - English - NLM (National Library of Medicine)

akorn - albuterol sulfate (unii: 021sef3731) (albuterol - unii:qf8svz843e) - albuterol 2 mg in 5 ml - albuterol sulfate syrup is indicated for the relief of bronchospasm in adults and children 2 years of age and older with reversible obstructive airway disease. albuterol sulfate syrup is contraindicated in patients with a history of hypersensitivity to albuterol or any of its components.

United States - English - NLM (National Library of Medicine)

actavis pharma, inc. - albuterol sulfate (unii: 021sef3731) (albuterol - unii:qf8svz843e) - albuterol 2 mg in 5 ml - albuterol sulfate syrup is indicated for the relief of bronchospasm in adults and children 2 years of age and older with reversible obstructive airway disease. albuterol sulfate syrup is contraindicated in patients with a history of hypersensitivity to albuterol or any of its components. safety and effectiveness in children below 2 years of age have not been established.

United States - English - NLM (National Library of Medicine)

nephron pharmaceuticals corporation - albuterol sulfate (unii: 021sef3731) (albuterol - unii:qf8svz843e) - albuterol 2.5 mg in 3 ml - albuterol sulfate inhalation solution is indicated for the relief of bronchospasm in patients 2 years of age and older with reversible obstructive airway disease and acute attacks of bronchospasm. albuterol sulfate inhalation solution is contraindicated in patients with a history of hypersensitivity to any of its components.

United States - English - NLM (National Library of Medicine)

nephron pharmaceuticals corporation - albuterol sulfate (unii: 021sef3731) (albuterol - unii:qf8svz843e) - albuterol 2.5 mg in 0.5 ml - albuterol sulfate inhalation solution is indicated for the relief of bronchospasm in patients 12 years of age and older with reversible obstructive airway disease and acute attacks of bronchospasm. albuterol sulfate inhalation solution is contraindicated in patients with a history of hypersensitivity to albuterol or any of its components.